AP NEWS

Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7

January 2, 2019

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan 2, 2019--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that members of the executive management team will participate in a fireside chat at the 37 th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7 at 9:30 a.m. Pacific Time.

The audio portion of the fireside chat will be accessible live through the company’s Investors page at http://investors.gilead.com/. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005115/en/

CONTACT: Sung Lee

Investor Relations

(650) 524-7792

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY HOSPITALS PHARMACEUTICAL

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2019.

PUB: 01/02/2019 09:01 AM/DISC: 01/02/2019 09:01 AM

http://www.businesswire.com/news/home/20190102005115/en

AP RADIO
Update hourly